Healthtech startup Inito secures US patent for diagnostic technology

Bengaluru-based healthtech startup Inito has secured patent rights from the United States Patent and Trademark Office (USPTO) for its flat-lens technology.

The patented flat-lens technology allows users to read medical test results via small devices, in a bid to facilitate lab-grade diagnostic tests at users’ homes.

“The sample is put on the test strip and the strip is inserted into the Inito device. The device is then attached to the phone whose camera captures images of the strip through the flat lens. The device also automatically calibrates the variations between different phones giving the same accuracy irrespective of the phone used. The Inito app displays the result and also tracks the values for analysis,” a statement from the company said on Monday.

Inito’s products include portable medical diagnostic tools to carry out 30 different tests including fertility tests, and devices that are smartphone-enabled to track health metrics such as diabetes, cholesterol levels and hormonal changes.

Having collected hormonal data through 150,000 and more tests to date, the startup claims to have a large cloud-based database on fertility hormones.

Inito plans to add eight more hormone tests to the device. It also plans to predict, diagnose medical conditions like anovulatory cycles and polycystic ovary syndrome before onset using Big Data analytics and artificial intelligence (AI) over its growing database.

Owned by Samplytics Technologies, Inito had been selected for the winter 2019 batch of US startup incubator Y Combinator.

Inito was set up in January 2015 by former Siemens employees Aayush Rai (IIT-Roorkee alumnus) and Varun AV (IIT-Madras graduate).